The Cartilage Regeneration Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Cartilage Regeneration Market is estimated to be USD 421.5 million in 2016 and predicted to rise to USD 818.71 million by 2021 with a CAGR of 14.2%. The market is segmented by Type of Treatment (Cell Based Approaches, Non-Cell Based Approaches, Chondrocyte Transplantation, Stem Cells, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), by Application (Hyaline Cartilage, Fibrocartilage). Further the market is geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The growth of the Global Cartilage Regeneration Market is mainly driven by factors such as increasing incidence of joint and bone disorders such as Osteoarthritis, which are a result of damage or wear and tear of connective tissues and the growing aging population with related connective tissue ailments. Furthermore, increase in the obese population and rising frequency of sports injuries & road accidents are set to boost market growth in the future. However, unfavorable reimbursement policies and the high cost of therapy are the major limitations of market growth.
The cell based approach, by the type of treatment segment has the major share of the cartilage regeneration market. It is also expanding with the highest CAGR among all other segments. This can be attributed to the long term benefits of cell based approach which make it a preferred mode of therapy. By the cell based approach segment, the chondrocyte transplantation segment holds the majority stake owing to long term benefits.
North America leads the market in 2016, with the U.S. accounting for a major share. North America is also expected to grow with the highest CAGR globally. Europe comes in second. The Asia-Pacific market is estimated to expand during the forecast period owing to higher joint and bone disorders resulting from a huge population base, coupled with increasing disposable incomes in the region. Middle-East and Africa are expected to witness market growth due to increase in the frequency of bone & joint related ailments and the availability of vast untapped markets.
The important players in the Cartilage Regeneration Market are CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), and Kedrion S.p.A (Italy), Bio Products Laboratory (U.K.), Sanquin (Netherland), China Biologic Products, Inc. (China), Biotest AG (Germany), and Laboratoire Français du Fractionnement et des Biotechnologies (France).
Browse through the full report at http://www.marketdataforecast.com/market-reports/global-cartilage-regeneration-market-2620/ and checkout our recent reports in the Plasma Fractionation category at http://www.marketdataforecast.com/subcategory/medical-devices-2/.For more insights and up-to-date industry news don’t forget subscribing to our newsletters.